Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 561 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document comprises formal letters to the National Stock Exchange of India under SEBI (Substantial Acquisition of Shares and Takeover) Regulation 31(4), disclosing promoter share encumbrance status (including confirmation of no encumbrance). It is a mandatory regulatory filing rather than a financial report (10-K, IR, ER, etc.), an acquisition/m&a, or a dividend/share capital announcement. It therefore falls into the general “Regulatory Filings” category (RNS).
2026-05-22 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 65% confidence The document consists of two letters from Ajooni Biotech to the National Stock Exchange of India disclosing under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations that the promoter and promoter group have not created any encumbrance on their shares for the year ended March 31, 2026. This is a mandatory regulatory compliance disclosure (a filing to satisfy stock exchange listing requirements), not an annual or interim report, earnings release, management discussion, or change in share capital. There is no financial data or executive management change information. It therefore falls under the general Regulatory Filings category.
2026-05-22 English
Outcome of Board Meeting
Regulatory Filings Classification · 75% confidence The document is a stock exchange disclosure under SEBI LODR Regulation 30 reporting the outcome of a board meeting and appointment of internal auditors. It does not contain financial statements or constitute an annual/interim report, nor is it a change in senior management. It is a routine regulatory compliance announcement that does not fit a more specific category.
2026-05-21 English
General Updates
Regulatory Filings Classification · 70% confidence The document is a formal intimation under Regulation 30 of SEBI (LODR) to the stock exchange notifying the appointment of internal auditors. It does not contain any financial results or audit findings, nor is it an actual audit report, annual/interim report, earnings release, or management discussion. It is a compliance announcement filed with the exchange. Therefore, it falls under the general regulatory announcements category (RNS).
2026-05-21 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011. It confirms that the promoters and persons acting in concert have not made any encumbrance over shares during the financial year ended March 31, 2026. This is a notification related to shareholding and encumbrance status, which aligns with the category of Major Shareholding Notification (MRQ). The document is short (2009 characters) and is a formal declaration to the stock exchange, not a financial report or other type of filing. Therefore, the appropriate classification is MRQ.
2026-05-06 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short communication from Ajooni Biotech Limited to the National Stock Exchange of India, informing that the company's website is updated and functional as per SEBI (LODR) Regulations, 2015. It is dated April 10, 2026, and signed by the Company Secretary. The content is an official notification about compliance with regulatory requirements regarding the company's website functionality. The document length is only 1210 characters, which is very short and does not contain any financial data, report, or detailed disclosures. It is not a financial report, audit, management discussion, or any other detailed filing. It is an announcement or notification to the stock exchange about a regulatory compliance matter. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-04-10 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.